Recent Advances and Trends in Biotechnology

​Experts define biotechnology as technologies, products, and services based on cellular and biomolecular processes, to improve the lives of humans and the health of the planet. Biotechnology is not a new concept, as humans have harnessed biological processes to create useful food products, including cheese and bread, for thousands of years. That said, the advent of technology over the last few decades, and more recently the rise of artificial intelligence (AI), has ushered in a new era of biotechnology.

Genetic engineering represents one of the latest biotechnology trends, particularly gene editing, synthetic biology (SynBio), and gene therapy. Gene editing has advanced leaps and bounds in recent years, as technologies such as CRISPR-Cas9 have allowed for extremely precise DNA manipulation. Trends in 2025 have often emphasized improved delivery systems, including lipid nanoparticles, which should make gene editing more common for broader clinical use in 2026 and beyond.

SynBio trends, meanwhile, involve a unique combination of biological processes and human engineering. As a result, scientists and engineers have completely rethought the production of biofuels, lab-grown meat, pharmaceuticals, and other important products. The future of SynBio appears very bright, with analysts projecting the field to reach $100 billion by 2030.

The United States Food and Drug Administration defines gene therapy as the modification of human genes to cure or treat a disease. More recently, gene therapy professionals have used techniques to take on more complex diseases, including conditions with polygenic roots. Thanks to advances in viral and non-viral delivery methods, gene therapies have become more effective and safer, which also allows doctors to combine gene therapy with other forms of treatment.

In addition to genetic engineering, many biotechnology trends involve AI-powered biotech research initiatives. AI-accelerated genomic analysis, for instance, has allowed researchers, scientists, and doctors to fully harness the rapidly expanding availability of genomic data. This insight has proven particularly useful for the development of targeted therapies. AI has also helped pharmaceutical leaders reimagine drug discovery, thanks to the technology's ability to run compound simulations. Machine learning models have made drug discovery both safer and more efficient.

Lastly, AI technology such as AlphaFold by DeepMind has yielded breakthroughs in protein folding, which can also improve targeted drug delivery, as well as enzyme production. Scientists have also combined AI-powered protein folding with CRISPR gene editing to advance the field of precision medicine.

Outside of genetic engineering and AI advances, the biotechnology industry has observed many advances in the areas of biomaterials and tissue engineering. For example, experts have harnessed the power of regenerative medicine to explore new cures and treatments for advanced diseases. Emerging gene and cell therapies, along with a range of tissue-engineered products, have demonstrated potential for treating different cancers and heart conditions, as well as neurological disorders, including Alzheimer's and Parkinson's. In the US alone, roughly 700 companies have engaged in cell-based therapeutic research. Pundits expect the stem cell storage sector to grow considerably over the next few years.

Other biomaterial and tissue engineering trends include advances in 3D bioprinting and the combination of nanotechnology and biotechnology. Additional biotechnology trends for 2026 and beyond range from microbiome research for both human and environmental health to progress in the field of mRNA and RNAi research.

Jason Sheasby

Shop